Are the high-costs of MS disease-modifying therapies justified?
Publication date: February 2018 Source:Multiple Sclerosis and Related Disorders, Volume 20 Author(s): Gavin Giovannoni, Chris Hawkes, Michael Levy, Emmanuelle Waubant
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Multiple Sclerosis | Neurology